Skip to main content

Zentalis Pharmaceuticals, Inc.

ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001725160

In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Zentalis Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
128
−10 vs. Q4 2021
Shares held
44.4M
+1.45M (+3.4%) vs. Q4 2021
Total value
$2.05B
−$1.56B (−43.2%) vs. Q4 2021
New holders
16
47 more added
Sold out
26
48 more reduced

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 128 institutions
Q1 2021: 95 institutionsQ2 2021: 120 institutionsQ3 2021: 116 institutionsQ4 2021: 139 institutionsQ1 2022: 128 institutionsQ2 2022: 122 institutionsQ3 2022: 121 institutionsQ4 2022: 106 institutionsQ1 2023: 110 institutionsQ2 2023: 134 institutionsQ3 2023: 137 institutionsQ4 2023: 120 institutionsQ1 2024: 142 institutionsQ2 2024: 145 institutionsQ3 2024: 136 institutionsQ4 2024: 142 institutionsQ1 2025: 132 institutionsQ2 2025: 117 institutionsQ3 2025: 99 institutionsQ4 2025: 86 institutionsQ1 2026: 102 institutionsQ2 2026: 114 institutions
Value heldQ1 2022: $2.05B
Q1 2021: $1.58BQ2 2021: $2.13BQ3 2021: $2.75BQ4 2021: $3.61BQ1 2022: $2.05BQ2 2022: $1.64BQ3 2022: $1.27BQ4 2022: $1.30BQ1 2023: $1.15BQ2 2023: $2.32BQ3 2023: $1.61BQ4 2023: $1.23BQ1 2024: $1.34BQ2 2024: $314.3MQ3 2024: $261.2MQ4 2024: $195.2MQ1 2025: $92.9MQ2 2025: $64.5MQ3 2025: $79.7MQ4 2025: $54.9MQ1 2026: $101.7MQ2 2026: $228.9M
Institutions holding ZNTL and their total value by quarter
QuarterHoldersValue
Q2 2026114$228.9M
Q1 2026102$101.7M
Q4 202586$54.9M
Q3 202599$79.7M
Q2 2025117$64.5M
Q1 2025132$92.9M
Q4 2024142$195.2M
Q3 2024136$261.2M
Q2 2024145$314.3M
Q1 2024142$1.34B
Q4 2023120$1.23B
Q3 2023137$1.61B
Q2 2023134$2.32B
Q1 2023110$1.15B
Q4 2022106$1.30B
Q3 2022121$1.27B
Q2 2022122$1.64B
Q1 2022128$2.05B
Q4 2021139$3.61B
Q3 2021116$2.75B
Q2 2021120$2.13B
Q1 202195$1.58B

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q4 2021.

Institutions holding ZNTL in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Affinity Asset Advisors, LLC207,500$9.57M3.80%+90,000+76.6%Added
Integral Health Asset Management, LLC215,000$9.92M2.58%+95,000+79.2%Added
Goldman Sachs Group Inc265,246$12.2M0.00%+123,877+87.6%Added
Charles Schwab Investment Management Inc267,837$12.4M0.00%+6,831+2.6%Added
Bank of America Corp284,248$13.1M0.00%+86,859+44.0%Added
Paradigm Biocapital Advisors LP287,577$13.3M3.51%−12,857−4.3%Reduced
Wellington Management Group LLP291,459$13.4M0.00%+139,014+91.2%Added
Northern Trust Corp339,231$15.7M0.00%−10,534−3.0%Reduced
Fiera Capital Corp369,086$17.0M0.04%+762+0.2%Added
Polar Capital Holdings Plc369,329$17.0M0.10%00.0%Unchanged
Allspring Global Investments Holdings, LLC410,081$18.9M0.02%−8,711−2.1%Reduced
Perceptive Advisors LLC501,509$23.1M0.48%+70,965+16.5%Added
Citadel Advisors LLC511,025$23.6M0.03%−88,611−14.8%Reduced
Geode Capital Management, LLC666,064$30.7M0.00%+4,853+0.7%Added
Capital World Investors683,000$31.5M0.01%00.0%Unchanged
Eventide Asset Management, LLC761,000$35.1M0.55%+232,000+43.9%Added
Federated Hermes, Inc.950,933$43.9M0.10%−23,727−2.4%Reduced
Alliancebernstein L.P.996,759$46.0M0.02%+69,822+7.5%Added
Primecap Management Co1,208,590$55.8M0.04%−45,050−3.6%Reduced
Viking Global Investors LPSuperinvestorViking Global Investors2,026,656$93.5M0.38%−91,628−4.3%Reduced
State Street Corp2,080,440$96.0M0.00%+734,024+54.5%Added
Tybourne Capital Management (HK) Ltd2,426,095$111.9M6.63%−202,314−7.7%Reduced
BlackRock Inc.2,842,580$131.2M0.00%−3650.0%Reduced
Avidity Partners Management LP3,176,999$146.6M3.25%+461,999+17.0%Added
Vanguard Group Inc3,240,585$149.5M0.00%+53,599+1.7%Added
Price T Rowe Associates Inc4,198,180$193.7M0.02%−184,701−4.2%Reduced
Matrix Capital Management Company, LP4,349,279$200.7M2.41%00.0%Unchanged
FMR LLC6,742,694$311.1M0.02%−53,137−0.8%Reduced
Holocene Advisors, LP0$00.00%−190,251−100.0%Sold out
Gamco Investors, Inc. Et Al0$00.00%−62,711−100.0%Sold out
Millennium Management LLC0$00.00%−35,966−100.0%Sold out
First Trust Advisors LP0$00.00%−32,932−100.0%Sold out
Putnam Investments LLC0$00.00%−30,194−100.0%Sold out
Tri Locum Partners LP0$00.00%−23,632−100.0%Sold out
Advisory Research Inc0$00.00%−19,770−100.0%Sold out
Bamco Inc0$00.00%−12,000−100.0%Sold out
STRS Ohio0$00.00%−11,000−100.0%Sold out
Ergoteles LLC0$00.00%−10,157−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−8,600−100.0%Sold out
Jane Street Group, LLC0$00.00%−5,289−100.0%Sold out
Victory Capital Management Inc0$00.00%−4,747−100.0%Sold out
Bank of Montreal0$00.00%−3,604−100.0%Sold out
Brown Advisory Inc0$00.00%−3,000−100.0%Sold out
Prudential Financial Inc0$00.00%−2,775−100.0%Sold out
Blueshift Asset Management, LLC0$00.00%−2,722−100.0%Sold out
Values First Advisors, Inc.0$00.00%−2,542−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−463−100.0%Sold out
First Horizon Advisors, Inc.0$00.00%−285−100.0%Sold out
Signet Financial Management, LLC0$00.00%−235−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−63−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−16−100.0%Sold out
Signaturefd, LLC0$00.00%−25−100.0%Sold out
Tarbox Family Office, Inc.0$00.00%−16−100.0%Sold out
Spire Wealth Management0$00.00%−14−100.0%Sold out
Carroll Financial Associates, Inc.––––Not filed